Core Philosophy
Reshape industries with AI, rebuild business with digital.
Core Team
Tsinghua-rooted "Optics-Electronics-Medicine-Data" R&D team + a market-savvy "Digital Healthcare" execution team — a decade of dedication
Lu Jianhua
Academician
Academician of the Chinese Academy of Sciences, Professor at Tsinghua University's Electronic Engineering Department, Chief Engineer of the Smart Sky-Net Innovation Project.
Gao Jiang
Founder
BSc in Electrical Engineering & Automation from Kunming University of Science and Technology. Former Marketing Director at Beijing Shouxin Co., Ltd. Currently leads corporate strategy and management.
Zhang Yong
Founder
BSc in Electronic Engineering from Tsinghua University, MSc in Information from UESTC. Former software engineer at Keytech (USA). Leads product and technology.
Wang Jingjing
PhD
BSc in Precision Instruments (Tsinghua), MSc in Physics (Peking University), PhD in Physics (University of Leeds). Senior optics researcher at Trinity College Dublin; National Overseas Talent; Senior Researcher at Huanjiang Lab (Zhejiang University).
Li Li
Chief Physician
Deputy Director of Yunnan Provincial Key Lab for Major Pediatric Diseases; Yunnan Medical Discipline Leader; Vice Chair of Yunnan Immunology Society; PhD supervisor.
Xu Jun
Chief Physician
MD from Sun Yat-sen University, postdoctoral fellow at University of Pittsburgh (USA). Chief Physician, Professor, and PhD supervisor at the Department of Neurology, Beijing Tiantan Hospital (Capital Medical University).
Journey: From Hardware R&D to Data Empowerment
Internet + Health
The founding team (Zhang Yong, Lu Jianhua, Gao Jiang, Liu Bin, et al.) visited Japan, Europe, the US, and Singapore to study product forms and directions, ultimately setting the founding direction as Internet + Health.
Baiquan Health Founded
Baiquan Health was formally established. Dropped gene / inflammation / protein testing paths in favor of element detection; Academician Lu confirmed the optical-technology route, and Dr. Wang Jingjing joined the team.
In-house R&D Established
After studying overseas products and surveying the domestic market, the team committed to the in-house product development route.
Product R&D Completed
BC408H prototype completed; Class II medical device registration process initiated.
Registration Approved
BC408H passed review and obtained the Class II medical device certificate ("Portable Skin Trace Element Monitor") and manufacturing license.
Mass Production · Clinical Research
Mass production of the device completed. Conducted clinical research at the First Affiliated Hospital of Kunming Medical University, collecting samples from over ten thousand people and building spectral-element reference ranges along with AI models for five chronic-disease groups.
Research Concluded · Lianbao Founded
Clinical research concluded; Lianbao Health was formally registered, opening a new commercialization stage.
Model Finalized · Market Pilot
Core AI model finalized; began real-world market pilots to validate the business model.
Industry Enablement · Hangxing First
Anti-drug rapid-screening model achieved breakthrough. Partnered with Beijing Hangxing Technology (China Aerospace's subsidiary): patent licensing + core component supply for co-built custom products; cross-population/region generalization modeling, and ten-thousand-scale dataset accumulation with multiple police bureaus.
Regional Enablement · Hangzhou
Hangzhou Shangcheng City Investment Group adopted our products with custom desktop units, full-scenario deployment and data assetization. Launched industry/regional empowerment replication; launched digital medical empowerment: pediatric specialty, adult specialty, infectious diseases (HBV, HIV).
Commercial Enablement · Self-operation
Partnered with China Mobile and the Data Exchange to launch "Doctor AI + Service Bundle", entering the self-operated commercial stage.
Our Direction & Boundaries
BC408H is a cumulative skin-spectrum status-assessment device. We are clear about its boundaries — we focus on making affordable, repeatable, long-term-trackable status assessment solid, extending the reach of gold-standard testing rather than replacing it.
✓ What We Do
- Continuous skin spectral feature capture: 400–700 nm visible-light diffuse reflectance, 1–4 mm effective penetration
- SDEI elementomics: reflects cumulative element-related status of skin tissue across week / month / year scales
- SCOPE skin chromophore omics: assessment of oxygenation, pigmentation, microcirculation and other chromophore-related status
- Long-term longitudinal monitoring: repeated follow-ups of the same subject, objectively visualizing status changes
- Risk grading and primary triage: triage placed ahead of hospital gold standards, expanding gold-standard reach
✕ What We Don't Do
- No disease diagnosis or treatment
- No specific supplement dosage prescription
- No real-time blood element / electrolyte / drug-concentration measurement
- No replacement of gold standards such as X-ray / ultrasound / blood testing
Affordable · Repeatable · Long-term trackable — placed ahead of gold standards, not replacing them.
Defined Application Directions
Elementomics Status Grading
For disease expression, chronic-disease management, nutrition assessment and health-check add-ons — graded references for cumulative element-related status.
Skin Chromophore Omics
For disease-deviation identification such as chronic oxidative-stress assessment, and medical aesthetics such as skin-health assessment and intervention tracking; presents a multi-dimensional physical spectral data profile of the skin.
Long-term Trend Monitoring
Baseline plus post-intervention follow-ups, objectively visualizing status-change trends to support health-management decisions.
Primary Risk Triage
For grassroots care, community health stations and large-scale screening — affordable primary triage, with high-risk cases referred to higher-level gold standards.
Lifestyle Grading Advice
Does not replace physician dosage prescriptions — provides qualitative plus semi-quantitative graded advisory suggestions aligned with nutrition-guideline ranges.
Partners
Working with regions, industries, medical institutions, and enterprises — empowering and co-building the digital health ecosystem
Corporate Culture
Integrity · Innovation · Inclusion · Responsibility — culture as the soul, public trust as the foundation.
A new era of non-invasive health
Using "Spectrum + AI" to make precise, safe, and inclusive health services accessible to everyone.
Global leader in spectral big-health data
Build a national big-health trust brand and bring the spectromics + AI data loop into medical, public-safety, sports, and public-health scenarios.
Integrity · Innovation · Inclusion · Responsibility
Unite the team within; earn trust without.
- Integrity first: keep compliance, build a brand on public trust
- Innovation as soul: break core barriers, drive industry upgrade
- Inclusion for all: bring technology to grassroots and the public
- Responsibility as guide: support Healthy China, social governance, and public welfare
Persistence · Pragmatism · Initiative · Collaboration
A decade of focus on non-invasive spectroscopy, building hardcore technology through long-termism.
- A decade of focus: patient, R&D-driven, no shortcuts
- Truth-first: data is verifiable, no exaggerated claims
- Pioneering spirit: first to combine Spectrum + AI dual-track detection
- United team: academicians · Tsinghua · top hospitals · industry pros
Certifications
ISO 13485 Medical Device Quality Management System
NMPA Medical Device Registration (China)
National High-Tech Enterprise
20+ Invention Patents
MPS 3rd Institute Test Report
Hainan Test Report
Yancheng Test Report